Trial presentation: β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

Cándido Villanueva  1    
1 Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona

Pathway
IBD, Oesophagus, Standards & Guidelines

Conference
UEG Week 2019

Social Sharing